{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-25-001003","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2025-06-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.042286+00:00","generated_at":"2026-05-18T19:08:42.016618+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Lipella Pharmaceuticals Delisted from Nasdaq, Plans to Relist on National Exchange","bullets":["Delisted from Nasdaq effective June 19, 2025 due to non-compliance with Listing Rules 5100, 5635, and 5640 regarding private placement transactions.","Common stock now quoted on OTC Pink Market under symbol LIPO; company remains fully reporting with SEC.","CEO Jonathan Kaufman issued stockholder letter detailing plans to submit initial listing application to another national exchange.","Clinical programs LP-310 (oral lichen planus) and LP-10 (hemorrhagic cystitis) continue unaffected; final LP-310 Phase 2a data expected H2 2025.","Company states delisting was not due to financial instability and maintains sufficient capital for development programs."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-25-001003","json":"https://secwatch.observer/filing/0001753926-25-001003.json","markdown":"https://secwatch.observer/filing/0001753926-25-001003.md","text":"https://secwatch.observer/filing/0001753926-25-001003.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392625001003/0001753926-25-001003-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392625001003/g084855_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-18T19:08:42.016618+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}